GC Cell unit supports Hanmi's obesity drug Phase 3 analysis
The collaboration adds analytical backing to Hanmi's late-stage obesity program as Korean developers push into the global metabolic market.
Read at Seoul Economic Daily →The collaboration adds analytical backing to Hanmi's late-stage obesity program as Korean developers push into the global metabolic market.
Read at Seoul Economic Daily →